Neurodegenerative diseases are closely related to aging and are caused by the loss of neuronal cells in the brain. To prevent neurodegenerative disorders, some bioactive materials, such as bioactive peptides, have been frequently studied for their pre...
Neurodegenerative diseases are closely related to aging and are caused by the loss of neuronal cells in the brain. To prevent neurodegenerative disorders, some bioactive materials, such as bioactive peptides, have been frequently studied for their preventive effects. Egg white protein is known as a valuable protein source for producing bioactive peptides and providing many biofunctional effective agents. Thus, this study was designed to confirm the neuroprotective effects of the egg white proteins, ovotransferrin and ovalbumin, and their hydrolysates against oxidatively stressed neuronal cells. In chapter 1, ovotransferrin was isolated from egg white protein and then hydrolyzed using Neutrase, pepsin, Protamex, and trypsin under optimum conditions. After that, the hydrolysates were used to validate neuroprotective effects. Hydrolyzed ovotransferrin showed higher antioxidative activities than pure ovotransferrin. Furthermore, 0.5 mg/mL of pepsin-derived ovotransferrin hydrolysate (OHPE) exhibited the highest cell viability (81.89%), and OHPE effectively reduced cellular reactive oxygen species (ROS) accumulation by 72% (as assessed by corrected total cell fluorescence) and decreased total apoptosis rate by 46.41%. These anti-apoptotic and antioxidative effects were demonstrated by the regulatory effects of OHPE on the mRNA and protein expression of Bax, Bcl-2, caspase-9, caspase-3, Nrf2, and HO-1, as well as on the mRNA expression of BDNF and TH. Additionally, nine peptides comprising OHPE were identified by LC-MS/MS and compared with the sequences that have antioxidant effects reported in Database of Food-derived bioactive peptides (DFBP) to explore their potential as antioxidants. In chapter 2, ovalbumin hydrolysates were produced using bromelain and papain at 37 ℃, pH 7.0, for 6 h and were then subjected to a cell viability test to investigate the neuroprotective effects of ovalbumin hydrolysates using bromelain (OAB) and papain (OAP). After optimal sample selection, morphological change observation, ROS production measurements, relative mRNA and protein expression analysis, apoptosis rates, and cell cycle analysis were conducted. According to the results, OAB showed the most effective protection at 1 mg/mL (96.40%) against oxidative stressed SH-SY5Y cells. OAB demonstrated the ability to regulate ROS production, apoptotic-related factor expressions, antioxidant production axis activation, and dopaminergic neuronal characteristics. In detail, OAB decreases Bax, caspase-9, and caspase-3 (pro-, active forms) expression and increases Bcl-2 expression. Additionally, OAB enhances the antioxidant production pathway by upregulating Nrf2 and HO-1 and promotes dopaminergic neuronal proliferation and function by enhancing BDNF and TH. Ultimately, this study suggested that OAB can be developed as a preventive agent against neurodegenerative diseases by inhibiting apoptotic neuronal cell death tendencies. These results indicate that selected the ovotransferrin hydrolysate, OHPE, and ovalbumin hydrolysate, OAB, can be used as nature-derived compounds to prevent neurodegenerative diseases by inhibiting ROS interactions and regulating protein expression in neuronal cells, ultimately inhibiting tendencies toward apoptotic neuronal cell death.